Himanshu Patel

Chief Executive Officer (CEO) & Co-Founder

Therapeutic Areas

Drug	Indication	Phase
Lumivascular CTO Crossing Platform	Chronic Total Occlusions (CTO) in Coronary Vessels	Pre-clinical